Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. - Wikidata - wikimedia - TriplyDB

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.

http://www.wikidata.org/entity/Q44483256

about

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.The role of antimicrobial stewardship in curbing carbapenem resistance.Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting.Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?Tigecycline: Alone or in combination?Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection.Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid.Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed.[Multiresistant gram-negative bacteria. A bacterial challenge of the twenty-first century].Combination therapy for extensively-drug resistant gram-negative bacteria.Is there a future for tigecycline?Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.

P2860

Q28484482-99D27F8C-F9EC-4FBC-97C0-CA870743EDF7 Q28550492-1EBD294D-05B0-4863-AF30-5F0B19D46EF0 Q33732524-3FABB3E7-B46E-41DC-8EA6-C6FBEDBA0232 Q34320945-13658B21-152D-4300-A7F3-71E6E7E056BA Q35101242-E1204A62-FBE5-4D7C-96D2-B15AD0A5E641 Q35700982-A7DE0C68-9F8B-43CD-8282-6ADB47F03315 Q36402290-11D4F08F-F202-4235-BA3B-B0D48FBD01FB Q36887794-FB48CDE2-DDD2-4C38-A13D-EAA219F3EF62 Q37026697-47DA5798-A4A7-4FA6-83D6-866B113EE200 Q37538614-76F42CFA-DC0C-4F79-9BB9-B460B0355123 Q37713697-DDB7C59C-99B0-4B3D-9399-069145F0A528 Q38097120-2E8205F7-3BD6-4DB8-A16D-1F27833FC4C7 Q38125493-E3DCD91C-1067-4E2C-9D7E-4879804BA940 Q38216011-4F328FE5-EF2F-477D-94B8-C7C5B98D5A52 Q38746707-54D7640F-FADE-4C46-B666-224CFE65E2B9 Q38953618-0E77AD67-E299-41FE-B9DD-7F4345D18618 Q38998702-58734271-1D40-46F0-9C6C-F7B61841ACEB Q39916184-04DE1095-1C52-46D8-9A92-8A059547E72A Q41351586-1E9AC44D-FA73-43CA-95AA-616F771849A0 Q41580349-D16EDDC4-21EC-4812-9C6C-65387B183B18 Q43226964-6CCE8F88-F27E-47EB-9FDE-FB8A21522929 Q43430110-8FCD1E82-6277-4BAD-A0B2-4C64F2F1FCB1 Q47819621-5487579A-61B8-417F-BFD3-33F5C6A4997E Q48908629-F80657D6-0F87-4EE1-AE1F-1F8C7DD23FFD Q51104523-7053DBE7-716A-4EAE-ABC8-BBC9DE862A13

P2860

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.

http://www.wikidata.org/entity/Q44483256

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@en

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@nl

type

label

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@en

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@nl

prefLabel

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@en

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@nl

P1433

Q44483256-02840DA1-EA13-4BB6-ABE8-F699877CC90A

P1476

Q44483256-6BE8A300-E665-444B-9D60-D008FC73AA02

P2093

Q44483256-08A4274A-DBB1-4EE0-9486-FFBD8004E2BE

Q44483256-0A4BF3FA-FA56-44C2-ABD2-E9FAFF16CF10

Q44483256-2A00D11C-3010-4C13-8F13-3DC5352A8DD1

Q44483256-2A7ADD19-1C87-4D3E-8675-066B15268545

Q44483256-4715F8A9-35F9-4550-BC42-115C0A0D5011

Q44483256-510EAADB-9420-4E62-928F-0CA9A5F3FD79

Q44483256-53F2E0D3-88B2-4694-9CDA-2767632D15F2

Q44483256-5BE99391-2CF5-434D-81C3-0FE8EC0ED213

Q44483256-93EA89BC-435E-4088-B1A1-8BE162A66FD2

Q44483256-AE73EEF7-80E8-49DF-811A-E1BD912DE4D7

P304

Q44483256-C641AF9B-8BE5-4EE2-9FE9-E63A447C713E

P31

Q44483256-F6271BB8-BD64-4CC1-B730-C758450F1756

P356

Q44483256-9997CBBF-0F31-481C-A2CC-C4470D9EDA1C

P433

Q44483256-900C5A0B-0227-4200-88EB-EE32904972EF

P478

Q44483256-C4270836-310B-4A47-BCC3-7CECEE4BA800

P50

Q44483256-39668DE8-9E9F-4D52-B3C9-A36D31BC9A8C

Q44483256-5D971013-9266-4F24-A2E3-02F227631311

Q44483256-7422A53A-C823-4ED1-AC4D-43B8309968C6

Q44483256-C8102F0B-35C1-4D22-B84C-11E7F8AC9629

P577

Q44483256-8F4345C8-4FC3-4861-9F1D-5FD0274B9E26

P698

Q44483256-ADFF51C3-79F3-449C-8E1D-4EFB7AF6FF45

P921

Q44483256-13A693B0-1D15-4E72-908E-E91FB1E905F9

Q44483256-50775366-970A-4374-BFB3-5607F9DC8306

P356

J.AJIC.2011.12.014

P1433

American Journal of Infection Control

P1476

Retrospective evaluation of co ...... Enterobacteriaceae infections.

@en

P2093

Dror Marchaim

http://www.w3.org/2001/XMLSchema#string

Emily T Martin

http://www.w3.org/2001/XMLSchema#string

Jason M Pogue

http://www.w3.org/2001/XMLSchema#string

Judy Moshos

http://www.w3.org/2001/XMLSchema#string

Keith S Kaye

http://www.w3.org/2001/XMLSchema#string

Michelle Campbell

http://www.w3.org/2001/XMLSchema#string

Namir Khandker

http://www.w3.org/2001/XMLSchema#string

Odaliz Abreu-Lanfranco

http://www.w3.org/2001/XMLSchema#string

Paul R Lephart

http://www.w3.org/2001/XMLSchema#string

Sorabh Dhar

http://www.w3.org/2001/XMLSchema#string

P304

983-987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJIC.2011.12.014

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Kayoko Hayakawa

Ashish Bhargava

P577

2012-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22440526

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

carbapenem antibiotic